These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7989026)

  • 1. Treated prevalence rates of severe mental illness among HMO members.
    Johnson RE; McFarland BH
    Hosp Community Psychiatry; 1994 Sep; 45(9):919-24. PubMed ID: 7989026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treated prevalence of bipolar disorder in a large staff-model HMO.
    Unützer J; Simon G; Pabiniak C; Bond K; Katon W
    Psychiatr Serv; 1998 Aug; 49(8):1072-8. PubMed ID: 9712215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrollment duration, service use, and costs of care for severely mentally ill members of a health maintenance organization.
    McFarland BH; Johnson RE; Hornbrook MC
    Arch Gen Psychiatry; 1996 Oct; 53(10):938-44. PubMed ID: 8857871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epidemiologic Catchment Area Program.
    Fichter MM; Narrow WE; Roper MT; Rehm J; Elton M; Rae DS; Locke BZ; Regier DA
    J Nerv Ment Dis; 1996 Oct; 184(10):598-606. PubMed ID: 8917156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do HMOs reduce outpatient mental health care costs?
    Norquist GS; Wells KB
    Am J Psychiatry; 1991 Jan; 148(1):96-101. PubMed ID: 1984713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antipsychotic medications in treating schizophrenia among different financing and delivery systems.
    Bloom JR; Cheng JS; Hu TW; Kang SH; Wallace N
    J Ment Health Policy Econ; 2003 Dec; 6(4):163-71. PubMed ID: 14713723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
    Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
    JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
    Gianfrancesco F; Pesa J; Wang RH
    J Manag Care Pharm; 2005 Apr; 11(3):220-30. PubMed ID: 15804206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey.
    McIntyre RS
    J Clin Psychiatry; 2009; 70 Suppl 3():5-11. PubMed ID: 19570496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders.
    Morgan VA; Mitchell PB; Jablensky AV
    Bipolar Disord; 2005 Aug; 7(4):326-37. PubMed ID: 16026485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia.
    Joshi K; Mao L; Biondi DM; Millet R
    BMC Psychiatry; 2018 Jan; 18(1):24. PubMed ID: 29378547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal accounts: my experiences as a psychiatric patient in the 1960s.
    Carney WR
    Psychiatr Serv; 2005 Dec; 56(12):1499-500. PubMed ID: 16339611
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between initial quetiapine dose and effectiveness as reflected in subsequent mental health service use among patients with schizophrenia or bipolar disorder.
    Gianfrancesco F; Wang RH; Pesa J
    Value Health; 2005; 8(4):471-8. PubMed ID: 16091024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of maternal mental health service users treated with mood stabilizing or antipsychotic medication.
    Møller-Olsen C; Friedman SH; Prakash C; North A
    Asia Pac Psychiatry; 2018 Jun; 10(2):e12304. PubMed ID: 29226616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health services within the HMO group.
    Levin BL
    HMO Pract; 1992 Sep; 6(3):16-21. PubMed ID: 10124511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium use and discontinuation in a health maintenance organization.
    Johnson RE; McFarland BH
    Am J Psychiatry; 1996 Aug; 153(8):993-1000. PubMed ID: 8678195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
    Ghaemi SN; Hsu DJ; Thase ME; Wisniewski SR; Nierenberg AA; Miyahara S; Sachs G
    Psychiatr Serv; 2006 May; 57(5):660-5. PubMed ID: 16675760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar disorder is often missed in people who misuse alcohol or drugs.
    Wise J
    BMJ; 2015 May; 350():h2766. PubMed ID: 26002967
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study.
    Wake DJ; Broughton P; Perera SM; MacIntyre DJ; Leese GP
    Psychoneuroendocrinology; 2016 Apr; 66():214-20. PubMed ID: 26849203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.